ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ư¼ºÈ¼¾ÅÍ ¾È³»
[¹®ÀÇÀüÈ] 1577-9966
Ư¼ºÈ¼¾Å͸¦ ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ư¼ºÈ¼¾ÅÍÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
°£Áúȯ¼¾ÅÍ
-
[SCI]
Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice
/ Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice
/ 201607
-
[SCI]
Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration of Regulatory T Cells
/ Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration of Regulatory T Cells
/ 201511
-
[SCI]
Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies
Kim HS, Yim HJ, Jang MK, Park JW, Suh SJ, Seo YS, Kim JH, Kim BH, Park SJ, Lee SH, Kim SG, Kim YS, Lee JI, Lee JW, Kim IH, Kim TY, Kim JW, Jeong SH, Jung YK, Park H, Hwang SG
/ Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies
/ 21(38):10874-82
/ 201510
-
[SCI]
Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma
Sohn BH, Shim JJ, Kim SB, Jang KY, Kim SM, Kim JH, Hwang JE, Jang HJ, Lee HS, Kim SC, Jeong W, Kim SS, Park ES, Heo J, Kim YJ, Kim DG, Leem SH, Kaseb AO, Hassan MM, Cha M, Chu IS, Johnson R, Park YY, Lee JS
/ Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma
/ 201510
-
[SCI]
Um SH BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A
Jung YK, Jung CH, Seo YS, Kim JH, Kim TH, Yoo YJ, Kang SH, Yim SY, Suh SJ, An H, Yim HJ, Yeon JE, Byun KS
/ Um SH BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A
/ 201509